APIs and Finished Drug Products
A Resilient and Reliable Supply of Life-Changing Medicines.
Phlow is on a bold mission to produce a reliable supply of the vital medicines necessary for the American population to sustain life and conquer disease.
Filling America’s Medicine Cabinet
Phlow leverages its R&D lab co-located next to the United States Pharmacopeia (USP), its state-of-the-art pharmaceutical manufacturing facilities, and its extensive partnership network to deliver advanced manufacturing solutions, including continuous manufacturing capabilities to provide a reliable and affordable supply of high-quality essential medicines.
Leading the Way to National Medicine Supply Chain Security
To date, Phlow has delivered more than 2 million doses of essential medicines to the SNS to support the U.S. government’s emergency response capabilities for the health of all Americans.
Putting Pediatric Patients First
A Sustainable, Domestic Supply of Life-Changing Medicines
The care of America’s children has been unnecessarily impacted by shortages of essential medicines, we are on a mission to fix this problem. Phlow’s finished drug portfolio is designed to start addressing this crisis and currently includes the following medicines with additional under development:

Rocuronium Bromide Injection
Form: Injection
Strength: 10 mg / mL
NDC Number: 81565-204-02





Furosemide Injection, USP
Form: Injection
Strength: 10 mg / mL
NDC Number: 81565-201-02





Dexamethasone Sodium Phosphate Injection, USP
Form: Injection
Strength: 4 mg / mL
NDC Number: 81565-202-02





Heparin Sodium Injection, USP
Form: Injection
Strength: 1000 USP units / mL
NDC Number: 81565-203-02
A Domestic API Pipeline Securing our Nation’s Essential Medicines Supply
Phlow continues to go beyond the boundaries of the status-quo with a pipeline specifically designed to address the shortages of essential medicine APIs critical to the health of our nation.


*DMF Filed on behalf of Phlow and in partnership with AMPAC Fine Chemicals – an SK Pharmteco Company.